artículo académico

• Scaled average bioequivalence methods for highly variable drugs: Leveling-off soft limits and the EMA's 2010 guideline (some ways to improve its type I error control).  STATISTICS IN MEDICINE.  43(7):1475-1488. 2024
• A STATISTICAL ANALYSIS FOR THE EPIDEMIOLOGICAL SURVEILLANCE OF COVID-19 IN CHILE.  SIGNA VITAE.  18(2):19-30. 2022
• BOOTSTRAPPING REGRESSION MODELS WITH LOCALLY STATIONARY DISTURBANCES.  TEST.  30:341-363. 2021
• CONTROLLING TYPE I ERROR IN THE REFERENCE-SCALED BIOEQUIVALENCE EVALUATION OF HIGHLY VARIABLE DRUGS.  PHARMACEUTICAL STATISTICS.  18(5):583-599. 2019
• CONSUMER'S RISK IN THE EMA AND FDA REGULATORY APPROACHES FOR BIOEQUIVALENCE IN HIGHLY VARIABLE DRUGS.  STATISTICS IN MEDICINE.  35(12):1933-1943. 2016